Current studentsExisting staffContact us
 

What are the implications of changing treatment delivery models for inflammatory bowel disease (IBD) sufferers?

Simple item page
dc.contributor.authorMikocka-Walus, A.A.
dc.contributor.authorAndrews, J.
dc.contributor.authorVon Kaenel, R.
dc.contributor.authorMoser, G.
dc.contributor.conferenceAustralian Gastroenterology Week 2012 (16 Oct 2012 - 19 Oct 2012 : Adelaide, SA)
dc.date.issued2012
dc.description.statementofresponsibilityAntonina A Mikocka-Walus, Jane Andrews, Roland Von Känel, Gabriele Moser
dc.identifier.citationJournal of Gastroenterology and Hepatology (Australia), 2012, vol.27, iss.Suppl. 4, pp.111-111
dc.identifier.doi10.1111/j.1440-1746.2011.07251_6.x
dc.identifier.issn0815-9319
dc.identifier.issn1440-1746
dc.identifier.orcidMikocka-Walus, A.A. [0000-0003-4864-3956]
dc.identifier.urihttp://hdl.handle.net/2440/91666
dc.language.isoen
dc.publisherWiley
dc.rights© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd
dc.source.urihttps://doi.org/10.1111/j.1440-1746.2011.07251_6.x
dc.titleWhat are the implications of changing treatment delivery models for inflammatory bowel disease (IBD) sufferers?
dc.typeConference item
pubs.publication-statusPublished

Files

Collections

Psychology publications